$OSIP Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in OSI PHARMACEUTICALS INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in OSI PHARMACEUTICALS INC. Get notifications about new insider transactions in OSI PHARMACEUTICALS INC for free.
Page: < prev 1 ... 2 3 4 5 6 7 8 9 10 ... 19 next >
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Mar 02 2007 | OSIP | OSI PHARMACEUTICAL ... | LUNDEMOSE ANKER MD, PH.D, DSC | Exec. VP & Pres. OS ... | Sell | S | 33.92 | 100 | 3,392 | 27,125 | 27.2 K to 27.1 K (-0.37 %) |
Mar 02 2007 | OSIP | OSI PHARMACEUTICAL ... | LUNDEMOSE ANKER MD, PH.D, DSC | Exec. VP & Pres. OS ... | Sell | S | 33.98 | 100 | 3,398 | 27,225 | 27.3 K to 27.2 K (-0.37 %) |
Mar 02 2007 | OSIP | OSI PHARMACEUTICAL ... | LUNDEMOSE ANKER MD, PH.D, DSC | Exec. VP & Pres. OS ... | Sell | S | 34.50 | 143 | 4,934 | 27,325 | 27.5 K to 27.3 K (-0.52 %) |
Mar 02 2007 | OSIP | OSI PHARMACEUTICAL ... | LOVENBERG WALTER M PHD | Director | Option Exercise | M | 6.50 | 6,668 | 43,342 | 0 | |
Mar 02 2007 | OSIP | OSI PHARMACEUTICAL ... | LOVENBERG WALTER M PHD | Director | Sell | S | 34.19 | 2,668 | 91,219 | 20,182 | 22.9 K to 20.2 K (-11.68 %) |
Mar 02 2007 | OSIP | OSI PHARMACEUTICAL ... | LOVENBERG WALTER M PHD | Director | Sell | S | 34.10 | 2,994 | 102,095 | 22,850 | 25.8 K to 22.9 K (-11.58 %) |
Mar 02 2007 | OSIP | OSI PHARMACEUTICAL ... | LOVENBERG WALTER M PHD | Director | Sell | S | 34.08 | 162 | 5,521 | 25,844 | 26 K to 25.8 K (-0.62 %) |
Mar 02 2007 | OSIP | OSI PHARMACEUTICAL ... | LOVENBERG WALTER M PHD | Director | Sell | S | 34.04 | 100 | 3,404 | 26,006 | 26.1 K to 26 K (-0.38 %) |
Mar 02 2007 | OSIP | OSI PHARMACEUTICAL ... | LOVENBERG WALTER M PHD | Director | Sell | S | 34.03 | 400 | 13,612 | 26,106 | 26.5 K to 26.1 K (-1.51 %) |
Mar 02 2007 | OSIP | OSI PHARMACEUTICAL ... | LOVENBERG WALTER M PHD | Director | Sell | S | 34.02 | 100 | 3,402 | 26,506 | 26.6 K to 26.5 K (-0.38 %) |
Mar 02 2007 | OSIP | OSI PHARMACEUTICAL ... | LOVENBERG WALTER M PHD | Director | Sell | S | 34.01 | 244 | 8,298 | 26,606 | 26.9 K to 26.6 K (-0.91 %) |
Mar 02 2007 | OSIP | OSI PHARMACEUTICAL ... | LOVENBERG WALTER M PHD | Director | Buy | M | 6.50 | 6,668 | 43,342 | 26,850 | 20.2 K to 26.9 K (+33.04 %) |
Feb 06 2007 | OSIP | OSI PHARMACEUTICAL ... | LOVENBERG WALTER M PHD | Director | Option Exercise | M | 6.50 | 6,666 | 43,329 | 6,668 | |
Feb 06 2007 | OSIP | OSI PHARMACEUTICAL ... | LOVENBERG WALTER M PHD | Director | Sell | S | 35.00 | 6,666 | 233,310 | 20,182 | 26.8 K to 20.2 K (-24.83 %) |
Feb 06 2007 | OSIP | OSI PHARMACEUTICAL ... | LOVENBERG WALTER M PHD | Director | Buy | M | 6.50 | 6,666 | 43,329 | 26,848 | 20.2 K to 26.8 K (+33.03 %) |
Feb 05 2007 | OSIP | OSI PHARMACEUTICAL ... | LUNDEMOSE ANKER MD, PH.D, DSC | Exec. VP & Pres. OS ... | Sell | S | 34.04 | 100 | 3,404 | 27,468 | 27.6 K to 27.5 K (-0.36 %) |
Feb 05 2007 | OSIP | OSI PHARMACEUTICAL ... | LUNDEMOSE ANKER MD, PH.D, DSC | Exec. VP & Pres. OS ... | Sell | S | 34.03 | 700 | 23,821 | 27,568 | 28.3 K to 27.6 K (-2.48 %) |
Feb 05 2007 | OSIP | OSI PHARMACEUTICAL ... | LUNDEMOSE ANKER MD, PH.D, DSC | Exec. VP & Pres. OS ... | Sell | S | 34.02 | 41 | 1,395 | 28,268 | 28.3 K to 28.3 K (-0.14 %) |
Feb 05 2007 | OSIP | OSI PHARMACEUTICAL ... | LUNDEMOSE ANKER MD, PH.D, DSC | Exec. VP & Pres. OS ... | Sell | S | 34.00 | 159 | 5,406 | 28,309 | 28.5 K to 28.3 K (-0.56 %) |
Jan 17 2007 | OSIP | OSI PHARMACEUTICAL ... | LOVENBERG WALTER M PHD | Director | Option Exercise | M | 6.50 | 6,666 | 43,329 | 13,334 | |
Jan 17 2007 | OSIP | OSI PHARMACEUTICAL ... | LOVENBERG WALTER M PHD | Director | Sell | S | 35.00 | 6,666 | 233,310 | 20,182 | 26.8 K to 20.2 K (-24.83 %) |
Jan 17 2007 | OSIP | OSI PHARMACEUTICAL ... | LOVENBERG WALTER M PHD | Director | Buy | M | 6.50 | 6,666 | 43,329 | 26,848 | 20.2 K to 26.8 K (+33.03 %) |
Dec 20 2006 | OSIP | OSI PHARMACEUTICAL ... | COSTA SANTO J | Director | Option Exercise | G | 30.39 | 25,000 | 759,750 | 25,000 | |
Dec 20 2006 | OSIP | OSI PHARMACEUTICAL ... | COSTA SANTO J | Director | Option Exercise | G | 30.39 | 25,000 | 759,750 | 0 | |
Dec 15 2006 | OSIP | OSI PHARMACEUTICAL ... | SIMON ROBERT L | Exec. VP, Core Dev. ... | Option Exercise | A | 37.74 | 11,250 | 424,575 | 11,250 | |
Dec 15 2006 | OSIP | OSI PHARMACEUTICAL ... | SIMON ROBERT L | Exec. VP, Core Dev. ... | Grant | A | 0.00 | 3,750 | 0 | 17,342 | 13.6 K to 17.3 K (+27.59 %) |
Dec 15 2006 | OSIP | OSI PHARMACEUTICAL ... | WOOD BARBARA A | V.P. & General Coun ... | Option Exercise | A | 37.74 | 15,000 | 566,100 | 15,000 | |
Dec 15 2006 | OSIP | OSI PHARMACEUTICAL ... | WOOD BARBARA A | V.P. & General Coun ... | Grant | A | 0.00 | 5,000 | 0 | 17,433 | 12.4 K to 17.4 K (+40.22 %) |
Dec 15 2006 | OSIP | OSI PHARMACEUTICAL ... | GIBSON NEIL | VP & Chief Scientif ... | Option Exercise | A | 37.74 | 15,000 | 566,100 | 15,000 | |
Dec 15 2006 | OSIP | OSI PHARMACEUTICAL ... | GIBSON NEIL | VP & Chief Scientif ... | Grant | A | 0.00 | 5,000 | 0 | 13,604 | 8.6 K to 13.6 K (+58.11 %) |
Dec 15 2006 | OSIP | OSI PHARMACEUTICAL ... | LUNDEMOSE ANKER MD, PH.D, DSC | Exec. VP & Pres. OS ... | Option Exercise | A | 37.74 | 20,000 | 754,800 | 20,000 | |
Dec 15 2006 | OSIP | OSI PHARMACEUTICAL ... | LUNDEMOSE ANKER MD, PH.D, DSC | Exec. VP & Pres. OS ... | Grant | A | 0.00 | 6,700 | 0 | 28,468 | 21.8 K to 28.5 K (+30.78 %) |
Dec 15 2006 | OSIP | OSI PHARMACEUTICAL ... | LEUNG GABRIEL | Exec. VP, Pres., (O ... | Option Exercise | A | 37.74 | 20,000 | 754,800 | 20,000 | |
Dec 15 2006 | OSIP | OSI PHARMACEUTICAL ... | LEUNG GABRIEL | Exec. VP, Pres., (O ... | Grant | A | 0.00 | 6,700 | 0 | 23,829 | 17.1 K to 23.8 K (+39.11 %) |
Dec 15 2006 | OSIP | OSI PHARMACEUTICAL ... | GODDARD COLIN | Chief Executive Off ... | Option Exercise | A | 37.74 | 37,500 | 1,415,250 | 37,500 | |
Dec 15 2006 | OSIP | OSI PHARMACEUTICAL ... | GODDARD COLIN | Chief Executive Off ... | Grant | A | 0.00 | 12,525 | 0 | 87,798 | 75.3 K to 87.8 K (+16.64 %) |
Dec 15 2006 | OSIP | OSI PHARMACEUTICAL ... | ATIEH MICHAEL G | Exec. VP & CFO | Option Exercise | A | 37.74 | 15,000 | 566,100 | 15,000 | |
Dec 15 2006 | OSIP | OSI PHARMACEUTICAL ... | ATIEH MICHAEL G | Exec. VP & CFO | Grant | A | 0.00 | 5,025 | 0 | 40,036 | 35 K to 40 K (+14.35 %) |
Dec 04 2006 | OSIP | OSI PHARMACEUTICAL ... | GRANNER DARYL K | Director | Option Exercise | M | 6.50 | 5,415 | 35,198 | 0 | |
Dec 04 2006 | OSIP | OSI PHARMACEUTICAL ... | GRANNER DARYL K | Director | Sell | S | 36.17 | 1,171 | 42,355 | 11,945 | 13.1 K to 11.9 K (-8.93 %) |
Dec 04 2006 | OSIP | OSI PHARMACEUTICAL ... | GRANNER DARYL K | Director | Sell | S | 36.13 | 100 | 3,613 | 13,116 | 13.2 K to 13.1 K (-0.76 %) |
Dec 04 2006 | OSIP | OSI PHARMACEUTICAL ... | GRANNER DARYL K | Director | Sell | S | 36.10 | 144 | 5,198 | 13,216 | 13.4 K to 13.2 K (-1.08 %) |
Dec 04 2006 | OSIP | OSI PHARMACEUTICAL ... | GRANNER DARYL K | Director | Sell | S | 36.32 | 164 | 5,956 | 13,360 | 13.5 K to 13.4 K (-1.21 %) |
Dec 04 2006 | OSIP | OSI PHARMACEUTICAL ... | GRANNER DARYL K | Director | Sell | S | 36.31 | 200 | 7,262 | 13,524 | 13.7 K to 13.5 K (-1.46 %) |
Dec 04 2006 | OSIP | OSI PHARMACEUTICAL ... | GRANNER DARYL K | Director | Sell | S | 36.30 | 100 | 3,630 | 13,724 | 13.8 K to 13.7 K (-0.72 %) |
Dec 04 2006 | OSIP | OSI PHARMACEUTICAL ... | GRANNER DARYL K | Director | Sell | S | 36.29 | 500 | 18,145 | 13,824 | 14.3 K to 13.8 K (-3.49 %) |
Dec 04 2006 | OSIP | OSI PHARMACEUTICAL ... | GRANNER DARYL K | Director | Sell | S | 36.27 | 436 | 15,814 | 14,324 | 14.8 K to 14.3 K (-2.95 %) |
Dec 04 2006 | OSIP | OSI PHARMACEUTICAL ... | GRANNER DARYL K | Director | Sell | S | 36.24 | 300 | 10,872 | 14,760 | 15.1 K to 14.8 K (-1.99 %) |
Dec 04 2006 | OSIP | OSI PHARMACEUTICAL ... | GRANNER DARYL K | Director | Sell | S | 36.22 | 300 | 10,866 | 15,060 | 15.4 K to 15.1 K (-1.95 %) |
Dec 04 2006 | OSIP | OSI PHARMACEUTICAL ... | GRANNER DARYL K | Director | Sell | S | 35.96 | 400 | 14,384 | 15,360 | 15.8 K to 15.4 K (-2.54 %) |
Dec 04 2006 | OSIP | OSI PHARMACEUTICAL ... | GRANNER DARYL K | Director | Sell | S | 35.95 | 400 | 14,380 | 15,760 | 16.2 K to 15.8 K (-2.48 %) |
Dec 04 2006 | OSIP | OSI PHARMACEUTICAL ... | GRANNER DARYL K | Director | Sell | S | 35.94 | 200 | 7,188 | 16,160 | 16.4 K to 16.2 K (-1.22 %) |
Dec 04 2006 | OSIP | OSI PHARMACEUTICAL ... | GRANNER DARYL K | Director | Sell | S | 35.80 | 29 | 1,038 | 16,360 | 16.4 K to 16.4 K (-0.18 %) |
Dec 04 2006 | OSIP | OSI PHARMACEUTICAL ... | GRANNER DARYL K | Director | Sell | S | 35.79 | 300 | 10,737 | 16,389 | 16.7 K to 16.4 K (-1.80 %) |
Dec 04 2006 | OSIP | OSI PHARMACEUTICAL ... | GRANNER DARYL K | Director | Sell | S | 35.78 | 100 | 3,578 | 16,689 | 16.8 K to 16.7 K (-0.60 %) |
Dec 04 2006 | OSIP | OSI PHARMACEUTICAL ... | GRANNER DARYL K | Director | Sell | S | 35.77 | 400 | 14,308 | 16,789 | 17.2 K to 16.8 K (-2.33 %) |
Dec 04 2006 | OSIP | OSI PHARMACEUTICAL ... | GRANNER DARYL K | Director | Sell | S | 35.76 | 171 | 6,115 | 17,189 | 17.4 K to 17.2 K (-0.99 %) |
Dec 04 2006 | OSIP | OSI PHARMACEUTICAL ... | GRANNER DARYL K | Director | Buy | M | 6.50 | 5,415 | 35,198 | 17,360 | 11.9 K to 17.4 K (+45.33 %) |
Dec 15 2006 | OSIP | OSI PHARMACEUTICAL ... | CAGNONI PABLO J | VP & Chief Medical ... | Grant | A | 0.00 | 6,700 | 0 | 6,710 | 10 to 6.7 K (+67,000.00 %) |
Oct 20 2006 | OSIP | OSI PHARMACEUTICAL ... | BROWNE G MORGAN | Director | Option Exercise | M | 6.75 | 10,000 | 67,500 | 5,000 | |
Oct 20 2006 | OSIP | OSI PHARMACEUTICAL ... | BROWNE G MORGAN | Director | Sell | D | 40.00 | 10,000 | 400,000 | 26,203 | 36.2 K to 26.2 K (-27.62 %) |
Oct 20 2006 | OSIP | OSI PHARMACEUTICAL ... | BROWNE G MORGAN | Director | Buy | M | 6.75 | 10,000 | 67,500 | 36,203 | 26.2 K to 36.2 K (+38.16 %) |
Aug 29 2006 | OSIP | OSI PHARMACEUTICAL ... | GODDARD COLIN | Chief Executive Off ... | Sell | S | 36.34 | 1,200 | 43,608 | 75,273 | 76.5 K to 75.3 K (-1.57 %) |
Aug 29 2006 | OSIP | OSI PHARMACEUTICAL ... | GODDARD COLIN | Chief Executive Off ... | Sell | S | 36.31 | 1,300 | 47,203 | 76,473 | 77.8 K to 76.5 K (-1.67 %) |
Aug 29 2006 | OSIP | OSI PHARMACEUTICAL ... | GODDARD COLIN | Chief Executive Off ... | Sell | S | 36.30 | 250 | 9,075 | 77,773 | 78 K to 77.8 K (-0.32 %) |
Aug 21 2006 | OSIP | OSI PHARMACEUTICAL ... | BROWNE G MORGAN | Director | Option Exercise | M | 6.50 | 5,000 | 32,500 | 0 | |
Aug 21 2006 | OSIP | OSI PHARMACEUTICAL ... | BROWNE G MORGAN | Director | Sell | S | 36.50 | 5,000 | 182,500 | 26,203 | 31.2 K to 26.2 K (-16.02 %) |
Aug 21 2006 | OSIP | OSI PHARMACEUTICAL ... | BROWNE G MORGAN | Director | Buy | M | 6.50 | 5,000 | 32,500 | 31,203 | 26.2 K to 31.2 K (+19.08 %) |
Aug 29 2006 | OSIP | OSI PHARMACEUTICAL ... | GODDARD COLIN | Chief Executive Off ... | Option Exercise | M | 7.88 | 30,000 | 236,250 | 0 | |
Aug 29 2006 | OSIP | OSI PHARMACEUTICAL ... | GODDARD COLIN | Chief Executive Off ... | Sell | S | 36.29 | 300 | 10,887 | 78,023 | 78.3 K to 78 K (-0.38 %) |
Aug 29 2006 | OSIP | OSI PHARMACEUTICAL ... | GODDARD COLIN | Chief Executive Off ... | Sell | S | 36.28 | 800 | 29,024 | 78,323 | 79.1 K to 78.3 K (-1.01 %) |
Aug 29 2006 | OSIP | OSI PHARMACEUTICAL ... | GODDARD COLIN | Chief Executive Off ... | Sell | S | 36.27 | 300 | 10,881 | 79,123 | 79.4 K to 79.1 K (-0.38 %) |
Aug 29 2006 | OSIP | OSI PHARMACEUTICAL ... | GODDARD COLIN | Chief Executive Off ... | Sell | S | 36.23 | 600 | 21,738 | 79,423 | 80 K to 79.4 K (-0.75 %) |
Aug 29 2006 | OSIP | OSI PHARMACEUTICAL ... | GODDARD COLIN | Chief Executive Off ... | Sell | S | 36.22 | 350 | 12,677 | 80,023 | 80.4 K to 80 K (-0.44 %) |
Aug 29 2006 | OSIP | OSI PHARMACEUTICAL ... | GODDARD COLIN | Chief Executive Off ... | Sell | S | 36.21 | 800 | 28,968 | 80,373 | 81.2 K to 80.4 K (-0.99 %) |
Aug 29 2006 | OSIP | OSI PHARMACEUTICAL ... | GODDARD COLIN | Chief Executive Off ... | Sell | S | 36.20 | 3,564 | 129,017 | 81,173 | 84.7 K to 81.2 K (-4.21 %) |
Aug 29 2006 | OSIP | OSI PHARMACEUTICAL ... | GODDARD COLIN | Chief Executive Off ... | Sell | S | 36.18 | 217 | 7,851 | 84,737 | 85 K to 84.7 K (-0.26 %) |
Aug 29 2006 | OSIP | OSI PHARMACEUTICAL ... | GODDARD COLIN | Chief Executive Off ... | Sell | S | 36.16 | 200 | 7,232 | 84,954 | 85.2 K to 85 K (-0.23 %) |
Aug 29 2006 | OSIP | OSI PHARMACEUTICAL ... | GODDARD COLIN | Chief Executive Off ... | Sell | S | 36.15 | 6,500 | 234,975 | 85,154 | 91.7 K to 85.2 K (-7.09 %) |
Aug 29 2006 | OSIP | OSI PHARMACEUTICAL ... | GODDARD COLIN | Chief Executive Off ... | Sell | S | 36.14 | 600 | 21,684 | 91,654 | 92.3 K to 91.7 K (-0.65 %) |
Aug 29 2006 | OSIP | OSI PHARMACEUTICAL ... | GODDARD COLIN | Chief Executive Off ... | Sell | S | 36.13 | 1,200 | 43,356 | 92,254 | 93.5 K to 92.3 K (-1.28 %) |
Aug 29 2006 | OSIP | OSI PHARMACEUTICAL ... | GODDARD COLIN | Chief Executive Off ... | Sell | S | 36.11 | 600 | 21,666 | 93,454 | 94.1 K to 93.5 K (-0.64 %) |
Aug 29 2006 | OSIP | OSI PHARMACEUTICAL ... | GODDARD COLIN | Chief Executive Off ... | Sell | S | 36.09 | 100 | 3,609 | 94,054 | 94.2 K to 94.1 K (-0.11 %) |
Aug 29 2006 | OSIP | OSI PHARMACEUTICAL ... | GODDARD COLIN | Chief Executive Off ... | Sell | S | 36.08 | 228 | 8,226 | 94,154 | 94.4 K to 94.2 K (-0.24 %) |
Aug 29 2006 | OSIP | OSI PHARMACEUTICAL ... | GODDARD COLIN | Chief Executive Off ... | Sell | S | 36.07 | 208 | 7,503 | 94,382 | 94.6 K to 94.4 K (-0.22 %) |
Aug 29 2006 | OSIP | OSI PHARMACEUTICAL ... | GODDARD COLIN | Chief Executive Off ... | Sell | S | 36.06 | 11 | 397 | 94,590 | 94.6 K to 94.6 K (-0.01 %) |
Aug 29 2006 | OSIP | OSI PHARMACEUTICAL ... | GODDARD COLIN | Chief Executive Off ... | Sell | S | 36.05 | 672 | 24,226 | 94,601 | 95.3 K to 94.6 K (-0.71 %) |
Aug 29 2006 | OSIP | OSI PHARMACEUTICAL ... | GODDARD COLIN | Chief Executive Off ... | Sell | S | 35.93 | 1,100 | 39,523 | 95,273 | 96.4 K to 95.3 K (-1.14 %) |
Aug 29 2006 | OSIP | OSI PHARMACEUTICAL ... | GODDARD COLIN | Chief Executive Off ... | Sell | S | 35.89 | 3,047 | 109,357 | 96,373 | 99.4 K to 96.4 K (-3.06 %) |
Aug 29 2006 | OSIP | OSI PHARMACEUTICAL ... | GODDARD COLIN | Chief Executive Off ... | Sell | S | 35.87 | 100 | 3,587 | 99,420 | 99.5 K to 99.4 K (-0.10 %) |
Aug 29 2006 | OSIP | OSI PHARMACEUTICAL ... | GODDARD COLIN | Chief Executive Off ... | Sell | S | 35.85 | 300 | 10,755 | 99,520 | 99.8 K to 99.5 K (-0.30 %) |
Aug 29 2006 | OSIP | OSI PHARMACEUTICAL ... | GODDARD COLIN | Chief Executive Off ... | Sell | S | 35.84 | 1,400 | 50,176 | 99,820 | 101.2 K to 99.8 K (-1.38 %) |
Aug 29 2006 | OSIP | OSI PHARMACEUTICAL ... | GODDARD COLIN | Chief Executive Off ... | Sell | S | 35.83 | 400 | 14,332 | 101,220 | 101.6 K to 101.2 K (-0.39 %) |
Aug 29 2006 | OSIP | OSI PHARMACEUTICAL ... | GODDARD COLIN | Chief Executive Off ... | Sell | S | 35.82 | 204 | 7,307 | 101,620 | 101.8 K to 101.6 K (-0.20 %) |
Aug 29 2006 | OSIP | OSI PHARMACEUTICAL ... | GODDARD COLIN | Chief Executive Off ... | Sell | S | 35.81 | 819 | 29,328 | 101,824 | 102.6 K to 101.8 K (-0.80 %) |
Aug 29 2006 | OSIP | OSI PHARMACEUTICAL ... | GODDARD COLIN | Chief Executive Off ... | Sell | S | 35.80 | 1,400 | 50,120 | 102,643 | 104 K to 102.6 K (-1.35 %) |
Aug 29 2006 | OSIP | OSI PHARMACEUTICAL ... | GODDARD COLIN | Chief Executive Off ... | Sell | S | 35.79 | 230 | 8,232 | 104,043 | 104.3 K to 104 K (-0.22 %) |
Aug 29 2006 | OSIP | OSI PHARMACEUTICAL ... | GODDARD COLIN | Chief Executive Off ... | Sell | S | 35.75 | 1,000 | 35,750 | 104,273 | 105.3 K to 104.3 K (-0.95 %) |
Aug 29 2006 | OSIP | OSI PHARMACEUTICAL ... | GODDARD COLIN | Chief Executive Off ... | Buy | M | 7.88 | 30,000 | 236,250 | 105,273 | 75.3 K to 105.3 K (+39.85 %) |
Aug 07 2006 | OSIP | OSI PHARMACEUTICAL ... | GIBSON NEIL | VP & Chief Scientif ... | Option Exercise | M | 15.49 | 2,000 | 30,980 | 7,000 | |
Aug 07 2006 | OSIP | OSI PHARMACEUTICAL ... | GIBSON NEIL | VP & Chief Scientif ... | Option Exercise | M | 21.55 | 834 | 17,973 | 0 | |
Aug 07 2006 | OSIP | OSI PHARMACEUTICAL ... | GIBSON NEIL | VP & Chief Scientif ... | Sell | S | 35.00 | 2,000 | 70,000 | 8,604 | 10.6 K to 8.6 K (-18.86 %) |
Aug 07 2006 | OSIP | OSI PHARMACEUTICAL ... | GIBSON NEIL | VP & Chief Scientif ... | Buy | M | 15.49 | 2,000 | 30,980 | 10,604 | 8.6 K to 10.6 K (+23.25 %) |
Aug 07 2006 | OSIP | OSI PHARMACEUTICAL ... | GIBSON NEIL | VP & Chief Scientif ... | Sell | S | 35.00 | 834 | 29,190 | 8,604 | 9.4 K to 8.6 K (-8.84 %) |
Aug 07 2006 | OSIP | OSI PHARMACEUTICAL ... | GIBSON NEIL | VP & Chief Scientif ... | Buy | M | 21.55 | 834 | 17,973 | 9,438 | 8.6 K to 9.4 K (+9.69 %) |
Jul 18 2006 | OSIP | OSI PHARMACEUTICAL ... | GODDARD COLIN | Chief Executive Off ... | Grant | A | 0.00 | 16,700 | 0 | 75,273 | 58.6 K to 75.3 K (+28.51 %) |
Jul 18 2006 | OSIP | OSI PHARMACEUTICAL ... | GIBSON NEIL | VP & Chief Scientif ... | Grant | A | 0.00 | 5,000 | 0 | 8,604 | 3.6 K to 8.6 K (+138.73 %) |
Jul 18 2006 | OSIP | OSI PHARMACEUTICAL ... | LUNDEMOSE ANKER MD, PH.D, DSC | Exec. VP & Pres. OS ... | Grant | A | 0.00 | 6,700 | 0 | 21,768 | 15.1 K to 21.8 K (+44.47 %) |
Jul 18 2006 | OSIP | OSI PHARMACEUTICAL ... | LEUNG GABRIEL | Exec. VP, Pres., (O ... | Grant | A | 0.00 | 6,700 | 0 | 17,129 | 10.4 K to 17.1 K (+64.24 %) |
Jul 18 2006 | OSIP | OSI PHARMACEUTICAL ... | SIMON ROBERT L | Exec. VP, Core Dev. ... | Grant | A | 0.00 | 5,000 | 0 | 13,366 | 8.4 K to 13.4 K (+59.77 %) |
Jul 18 2006 | OSIP | OSI PHARMACEUTICAL ... | ATIEH MICHAEL G | Exec. VP & CFO | Grant | A | 0.00 | 6,700 | 0 | 35,011 | 28.3 K to 35 K (+23.67 %) |
Jul 18 2006 | OSIP | OSI PHARMACEUTICAL ... | WOOD BARBARA A | V.P. & General Coun ... | Grant | A | 0.00 | 5,000 | 0 | 12,433 | 7.4 K to 12.4 K (+67.27 %) |
Jul 18 2006 | OSIP | OSI PHARMACEUTICAL ... | BROWNE G MORGAN | Director | Grant | A | 0.00 | 1,500 | 0 | 26,603 | 25.1 K to 26.6 K (+5.98 %) |
Jul 18 2006 | OSIP | OSI PHARMACEUTICAL ... | GRANNER DARYL K | Director | Grant | A | 0.00 | 1,500 | 0 | 11,945 | 10.4 K to 11.9 K (+14.36 %) |
Jul 18 2006 | OSIP | OSI PHARMACEUTICAL ... | MEHTA VIREN | Director | Grant | A | 0.00 | 1,500 | 0 | 79,751 | 78.3 K to 79.8 K (+1.92 %) |
Jul 18 2006 | OSIP | OSI PHARMACEUTICAL ... | LOVENBERG WALTER M PHD | Director | Grant | A | 0.00 | 1,500 | 0 | 20,182 | 18.7 K to 20.2 K (+8.03 %) |
Jul 18 2006 | OSIP | OSI PHARMACEUTICAL ... | RICHMOND MARK | Director | Grant | A | 0.00 | 1,500 | 0 | 5,323 | 3.8 K to 5.3 K (+39.24 %) |
Jul 18 2006 | OSIP | OSI PHARMACEUTICAL ... | PINEDO HERBERT MD PHD | Director | Grant | A | 0.00 | 1,500 | 0 | 3,967 | 2.5 K to 4 K (+60.80 %) |
Jul 18 2006 | OSIP | OSI PHARMACEUTICAL ... | STEVENSON KATHARINE BERGHUIS | Director | Grant | A | 0.00 | 1,500 | 0 | 4,990 | 3.5 K to 5 K (+42.98 %) |
Jul 18 2006 | OSIP | OSI PHARMACEUTICAL ... | WHITE JOHN P | Director | Grant | A | 0.00 | 1,500 | 0 | 20,823 | 19.3 K to 20.8 K (+7.76 %) |
Jul 18 2006 | OSIP | OSI PHARMACEUTICAL ... | COSTA SANTO J | Director | Grant | A | 0.00 | 8,500 | 0 | 8,500 | 0 to 8.5 K |
Jul 18 2006 | OSIP | OSI PHARMACEUTICAL ... | INGRAM ROBERT ALEXANDER | Director | Grant | A | 0.00 | 3,000 | 0 | 18,886 | 15.9 K to 18.9 K (+18.88 %) |
Jul 18 2006 | OSIP | OSI PHARMACEUTICAL ... | KLEIN JOSEPH III | Director | Grant | A | 0.00 | 8,500 | 0 | 11,500 | 3 K to 11.5 K (+283.33 %) |
Jul 18 2006 | OSIP | OSI PHARMACEUTICAL ... | NIEMIEC DAVID W | Director | Grant | A | 0.00 | 8,500 | 0 | 8,500 | 0 to 8.5 K |
Jun 16 2006 | OSIP | OSI PHARMACEUTICAL ... | MEHTA VIREN | Director | Option Exercise | A | 30.39 | 3,000 | 91,170 | 3,000 | |
Jun 16 2006 | OSIP | OSI PHARMACEUTICAL ... | STEVENSON KATHARINE BERGHUIS | Director | Option Exercise | A | 30.39 | 3,000 | 91,170 | 3,000 | |
Jun 16 2006 | OSIP | OSI PHARMACEUTICAL ... | PINEDO HERBERT MD PHD | Director | Option Exercise | A | 30.39 | 3,000 | 91,170 | 3,000 | |
Jun 16 2006 | OSIP | OSI PHARMACEUTICAL ... | GRANNER DARYL K | Director | Option Exercise | A | 30.39 | 3,000 | 91,170 | 3,000 | |
Jun 16 2006 | OSIP | OSI PHARMACEUTICAL ... | LOVENBERG WALTER M PHD | Director | Option Exercise | A | 30.39 | 3,000 | 91,170 | 3,000 | |
Jun 16 2006 | OSIP | OSI PHARMACEUTICAL ... | WHITE JOHN P | Director | Option Exercise | A | 30.39 | 3,000 | 91,170 | 3,000 | |
Jun 16 2006 | OSIP | OSI PHARMACEUTICAL ... | BROWNE G MORGAN | Director | Option Exercise | A | 30.39 | 3,000 | 91,170 | 3,000 | |
Jun 16 2006 | OSIP | OSI PHARMACEUTICAL ... | COSTA SANTO J | Director | Option Exercise | A | 30.39 | 25,000 | 759,750 | 25,000 | |
Jun 16 2006 | OSIP | OSI PHARMACEUTICAL ... | RICHMOND MARK | Director | Option Exercise | A | 30.39 | 3,000 | 91,170 | 3,000 | |
Jun 16 2006 | OSIP | OSI PHARMACEUTICAL ... | KLEIN JOSEPH III | Director | Option Exercise | A | 30.39 | 25,000 | 759,750 | 25,000 | |
Jun 16 2006 | OSIP | OSI PHARMACEUTICAL ... | NIEMIEC DAVID W | Director | Option Exercise | A | 30.39 | 25,000 | 759,750 | 25,000 | |
Jun 16 2006 | OSIP | OSI PHARMACEUTICAL ... | INGRAM ROBERT ALEXANDER | Director | Option Exercise | A | 30.39 | 6,000 | 182,340 | 6,000 | |
Jun 15 2006 | OSIP | OSI PHARMACEUTICAL ... | WOOD BARBARA A | V.P. & General Coun ... | Option Exercise | A | 29.77 | 15,000 | 446,550 | 15,000 | |
Jun 15 2006 | OSIP | OSI PHARMACEUTICAL ... | ATIEH MICHAEL G | Exec. VP & CFO | Option Exercise | A | 29.77 | 20,000 | 595,400 | 20,000 | |
Jun 15 2006 | OSIP | OSI PHARMACEUTICAL ... | SIMON ROBERT L | Exec. VP, Core Dev. ... | Option Exercise | A | 29.77 | 15,000 | 446,550 | 15,000 | |
Jun 15 2006 | OSIP | OSI PHARMACEUTICAL ... | LEUNG GABRIEL | Exec. VP, Pres., (O ... | Option Exercise | A | 29.77 | 20,000 | 595,400 | 20,000 | |
Jun 15 2006 | OSIP | OSI PHARMACEUTICAL ... | LUNDEMOSE ANKER MD, PH.D, DSC | Exec. VP & Pres. OS ... | Option Exercise | A | 29.77 | 20,000 | 595,400 | 20,000 | |
Jun 15 2006 | OSIP | OSI PHARMACEUTICAL ... | GODDARD COLIN | Chief Executive Off ... | Option Exercise | A | 29.77 | 50,000 | 1,488,500 | 50,000 | |
Jun 15 2006 | OSIP | OSI PHARMACEUTICAL ... | GIBSON NEIL | VP & Chief Scientif ... | Option Exercise | A | 29.77 | 15,000 | 446,550 | 15,000 | |
Jun 06 2006 | OSIP | OSI PHARMACEUTICAL ... | GODDARD COLIN | Chief Executive Off ... | Option Exercise | M | 9.00 | 24,000 | 216,000 | 0 | |
Jun 06 2006 | OSIP | OSI PHARMACEUTICAL ... | GODDARD COLIN | Chief Executive Off ... | Sell | S | 30.28 | 697 | 21,105 | 58,573 | 59.3 K to 58.6 K (-1.18 %) |
Jun 06 2006 | OSIP | OSI PHARMACEUTICAL ... | GODDARD COLIN | Chief Executive Off ... | Sell | S | 30.25 | 10,303 | 311,666 | 59,270 | 69.6 K to 59.3 K (-14.81 %) |
Jun 06 2006 | OSIP | OSI PHARMACEUTICAL ... | GODDARD COLIN | Chief Executive Off ... | Sell | S | 30.09 | 2,200 | 66,198 | 69,573 | 71.8 K to 69.6 K (-3.07 %) |
Jun 06 2006 | OSIP | OSI PHARMACEUTICAL ... | GODDARD COLIN | Chief Executive Off ... | Sell | S | 30.08 | 30 | 902 | 71,773 | 71.8 K to 71.8 K (-0.04 %) |
Jun 06 2006 | OSIP | OSI PHARMACEUTICAL ... | GODDARD COLIN | Chief Executive Off ... | Sell | S | 30.05 | 400 | 12,020 | 71,803 | 72.2 K to 71.8 K (-0.55 %) |
Jun 06 2006 | OSIP | OSI PHARMACEUTICAL ... | GODDARD COLIN | Chief Executive Off ... | Sell | S | 30.03 | 502 | 15,075 | 72,203 | 72.7 K to 72.2 K (-0.69 %) |